0
Grand Rounds |

Pemphigus—Diseases of Antidesmosomal Autoimmunity

Mark C. Udey, MD, PhD; John R. Stanley, MD
JAMA. 1999;282(6):572-576. doi:10.1001/jama.282.6.572.
Text Size: A A A
Published online

Extract

Marinkovich MP, Herron GS, Kavari PA, Bauer EA.Hereditary epidermolysis bullosa.In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999:690-702.
Stanley JR.Pemphigus.In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999:654-666.
Anhalt G, Kim S, Stanley J.  et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med.1990;323:1729-1735.
Anhalt GJ.Paraneoplastic pemphigus. Adv Dermatol.1997;12:77-96.
Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley J.Autoantibodies against the amino-terminal cadherin-like domain of pemphigus vulgaris are pathogenic. J Clin Invest.1992;90:919-926.
Lin MS, Mascaro JM, Liu Z, Espana A, Diaz LA.The desmosome and hemidesmosome in cutaneous autoimmunity. Clin Exp Immunol.1997;107(suppl 1):9S-15S.
Sams WMJ, Jordan RE.Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol.1971;84:7-13.
Ishii K, Amagai M, Hall RP.  et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant proteins. J Immunol.1997;159:2010-2017.
Chowdhury MMU, Natarajan S.Neonatal pemphigus associated with mild oral pemphigus vulgaris in the mother during pregnancy. Br J Dermatol.1998;139:500-503.
Schlitz JR, Micheal B.Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol.1976;67:254-260.
Hashimoto K, Shafran KM, Webber PS, Lazaraus GS, Singer KH.Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J Exp Med.1983;157:259-272.
Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA.Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med.1982;306:1189-1196.
Roscoe JT, Diaz L, Sampaio SA.  et al. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol.1985;85:538-541.
Amagai M.Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol.1996;11:319-352.
Kowalcyk AP, Bornslaeger EA, Norvell SM, Palka HL, Green KJ.Desmosomes: intracellular adhesive junctions specialized for attachment of intermediate filaments. Int Rev Cytol.1999;185:237-302.
Ding X, Aoki V, Mascaro JM, Lopez-Swiderski A, Diaz LA, Fairley JA.Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct antibody profiles. J Invest Dermatol.1997;109:592-596.
Amagai M, Nishikawa T, Nousari H.Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest.1998;102:775-782.
Mahoney MG, Aho S, Uitto JR, Stanley JR.The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol.1998;111:308-313.
Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T.Antigen-specific immunoabsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol.1995;104:895-901.
Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T.Absorption of pathogenic antibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest.1994;94:59-67.
Koch PJ, Mahoney MG, Ishikawa H.  et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol.1997;137:1091-1102.
Mahoney MG, Wang Z, Rothenberger K.  et al. Explanations for the clinical and microscopic localization of lesions of pemphigus foliaceus and pemphigus vulgaris. J Clin Invest.1999;103:461-468.
Wucherpfennig KW, Yu B, Bhol K.  et al. Structural basis for major histocompatibilty complex (MHC)–linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A.1995;92:11935-11939.
Lin MS, Swartz SJ, Lopez A.  et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest.1997;99:31-40.
Cohen PL.Systemic autoimmunity.In: Paul WE, ed. Fundamental Immunology. Philadelphia, Pa: Lippincott-Raven; 1999:1067-1088.
Shevach EM.Organ-specific autoimmunity.In: Paul WE, ed. Fundamental Immunology. Philadelphia, Pa: Lippincott-Raven; 1999:1089-1125.
Sampaio SA, Rivitti EA, Aoki V, Daiz LA.Brazilian pemphigus foliaceus, endemic pemphigus foliaceus, or fogo selvagem (wild fire). Dermatol Clin.1994;12:765-776.
Moraes ME, Fernandez-Vina M, Lazaro A.  et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens.1997;49:35-40.
Eaton DP, Diaz LA, Hans-Filho G.  et al. for The Cooperative Group on Fogo Selvagem Research. Comparison of black fly species (Diptera: Simuliidae) on an Amerindian reservation with a high prevalence of fogo selvagem to neighboring disease-free sites in the state of Mato Grosso do Sol, Brazil. J Med Entomol.1998;35:120-131.
Huilgol SC, Black MM.Management of the immunobullous disorders, II: pemphigus. Clin Exp Dermatol.1995;20:283-293.
Bystryn JC, Steinman NM.The adjuvant therapy of pemphigus. Arch Dermatol.1996;132:203-212.
Stanley JR.Therapy of pemphigus vulgaris. Arch Dermatol.1999;135:76-78.
Enk AH, Knop J.Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol.1999;135:54-56.
Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Figure 1. Clinical and Histologic Features of Pemphigus
Graphic Jump Location
A, Stomatitis in a patient with pemphigus vulgaris (PV). B, Erosions typical of PV. C, Histology of a PV skin lesion revealing suprabasilar acantholysis (hematoxylin-eosin stain, original magnification ×40). D, Indirect immunofluorescence testing of PV serum sample showing diagnostic antikeratinocyte IgG reactivity (monkey esophagus as substrate). E, Crusted erythematous skin lesions of pemphigus foliaceus. F, Histology of a pemphigus foliaceus lesion demonstrating the characteristic subcorneal intraepidermal cleavage (hematoxylin-eosin, original magnification × 40).
Figure 2. Structural Features of Desmosomes
Graphic Jump Location
Schematic representation of the current consensus view of protein-protein interactions in desmosomes. Many desmosomal components (including other members of the plakin family) are not depicted because their physical relationships to other desmosomal components are not yet well characterized.15Dsg indicates desmogleins.
Figure 3. The Desmoglein Compensation Hypothesis
Graphic Jump Location
Pemphigus foliaceus sera contain only anti–desmoglein (Dsg) 1 antibodies and cause blisters by interfering with the function of Dsg1, where there is no Dsg3 to compensate, namely, in the superficial epidermis of skin. In early pemphigus vulgaris, when patients produce only anti-Dsg3 antibodies, separations develop deep in mucous membranes, where Dsg1 will not compensate for loss of Dsg3-mediated adhesion. Later in the course of pemphigus vulgaris, when the patients' sera contain both anti-Dsg1 and anti-Dsg3 antibodies, the function of both Dsgs is compromised and blisters occur in skin and mucous membranes. Arrow indicates that the antibody is capable of causing blisters; X, blister formation is blocked by the compensating Dsg. The triangles represent the distribution of Dsg1 and Dsg3.

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 55

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();